BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23108648)

  • 1. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
    Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor γ attenuates serotonin-induced pulmonary artery smooth muscle cell proliferation and apoptosis inhibition involving ERK1/2 pathway.
    Han X; Chen C; Cheng G; Liang L; Yao X; Yang G; You P; Shou X
    Microvasc Res; 2015 Jul; 100():17-24. PubMed ID: 25937083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid EP
    Li HH; Hsu HH; Chang GJ; Chen IC; Ho WJ; Hsu PC; Chen WJ; Pang JS; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L349-L359. PubMed ID: 29146573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
    Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-γ enhances human pulmonary artery smooth muscle cell apoptosis through microRNA-21 and programmed cell death 4.
    Green DE; Murphy TC; Kang BY; Bedi B; Yuan Z; Sadikot RT; Hart CM
    Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L371-L383. PubMed ID: 28522568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.
    Zhang D; Wang G; Han D; Zhang Y; Xu J; Lu J; Li S; Xie X; Liu L; Dong L; Li M
    Life Sci; 2014 Mar; 98(1):39-43. PubMed ID: 24412385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
    Calvier L; Boucher P; Herz J; Hansmann G
    Circ Res; 2019 Jun; 124(12):1778-1785. PubMed ID: 31023188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.
    Liu Y; Wang Z; Li J; Ban Y; Mao G; Zhang M; Wang M; Liu Y; Zhao B; Shen Q; Xu Q; Wang N
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29382665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q; Chen Y; Chen X; Zhang J; Lu W; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation.
    Hansmann G; Wagner RA; Schellong S; Perez VA; Urashima T; Wang L; Sheikh AY; Suen RS; Stewart DJ; Rabinovitch M
    Circulation; 2007 Mar; 115(10):1275-84. PubMed ID: 17339547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ; Hsu HC; Ho WJ; Chang GJ; Pang JS; Chen WJ; Huang CC; Lai YJ
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L1-L13. PubMed ID: 31017016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis.
    Jiang Q; Lu W; Yang K; Hadadi C; Fu X; Chen Y; Yun X; Zhang J; Li M; Xu L; Tang H; Yuan JX; Wang J; Sun D
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C136-49. PubMed ID: 27194472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological activation of PPARγ inhibits hypoxia-induced proliferation through a caveolin-1-targeted and -dependent mechanism in PASMCs.
    Yang K; Zhao M; Huang J; Zhang C; Zheng Q; Chen Y; Jiang H; Lu W; Wang J
    Am J Physiol Cell Physiol; 2018 Apr; 314(4):C428-C438. PubMed ID: 29351409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.
    Lu X; Bijli KM; Ramirez A; Murphy TC; Kleinhenz J; Hart CM
    Free Radic Biol Med; 2013 Oct; 63():151-60. PubMed ID: 23684777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR{gamma} regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-{kappa}B.
    Lu X; Murphy TC; Nanes MS; Hart CM
    Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L559-66. PubMed ID: 20622120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.
    Guignabert C; Alvira CM; Alastalo TP; Sawada H; Hansmann G; Zhao M; Wang L; El-Bizri N; Rabinovitch M
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1082-90. PubMed ID: 19801450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.